RENHE PHARMACY CO., LTD. |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.53 CNY | +0.15% |
|
-1.36% | -1.51% |
| 29/04 | Renhe Pharmacy Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 26/04 | Renhe Pharmacy Co., Ltd. Proposes Final Cash Dividend for the Year 2023 | CI |
| Sales 2022 | 5.15B 712M 59.39B | Sales 2023 | 5.03B 695M 57.99B | Capitalization | 9.28B 1.28B 107B |
|---|---|---|---|---|---|
| Net income 2022 | 574M 79.29M 6.61B | Net income 2023 | 567M 78.32M 6.53B | EV / Sales 2022 | 1 x |
| Net cash position 2022 | 3.52B 486M 40.56B | Net cash position 2023 | 3.37B 466M 38.88B | EV / Sales 2023 | 1.17 x |
| P/E ratio 2022 |
15.1
x | P/E ratio 2023 |
16.2
x | Employees | 6,062 |
| Yield 2022 |
3.23% | Yield 2023 |
-
| Free-Float | 68.41% |
More Fundamentals
* Assessed data
More news
| 1 day | +0.15% | ||
| 1 week | -1.36% | ||
| Current month | -0.61% | ||
| 1 month | -0.61% | ||
| 3 months | +5.66% | ||
| 6 months | -2.97% | ||
| Current year | -1.51% |
1 week
6.36
6.80
1 month
6.366.80
Current year
5.096.86
1 year
5.097.59
3 years
5.0912.82
5 years
5.0912.82
10 years
3.6617.28
| Managers | Title | Age | Since |
|---|---|---|---|
Wu Jun Huang
CEO | Chief Executive Officer | 56 | 11/15/11 |
Qiu Lin Peng
DFI | Director of Finance/CFO | 58 | 31/09/31 |
Zi Qiang Zhang
BRD | Director/Board Member | 53 | 25/12/25 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shu Tian Tu
BRD | Director/Board Member | 62 | - |
Zheng Lian Xiao
BRD | Director/Board Member | 56 | 25/06/25 |
Qiu Lin Peng
DFI | Director of Finance/CFO | 58 | 31/09/31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.21% | 4 M€ | -2.96% | ||
| 0.00% | 34 M€ | +1.32% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/24/30 | 6.53 | +0.15% | 46,035,360 |
| 29/24/29 | 6.52 | -0.46% | 52,892,630 |
| 26/24/26 | 6.55 | -3.53% | 63,528,860 |
| 25/24/25 | 6.79 | +1.04% | 23,730,570 |
| 24/24/24 | 6.72 | +0.30% | 17,042,800 |
End-of-day quote Shenzhen S.E., April 30, 2024
More quotes
RENHE PHARMACY CO.,LTD is a China-based company principally engaged in pharmaceutical industry. The Company is mainly engaged in medical industrial manufacturing and medical merchandising. The Companyâs main products include capsules, granules, tablets, powder, injections, suppositories and ointment, among others. The Company is also involved in the wholesaling and retailing of health-related products. The Company distributes its products mainly in domestic market.
Sector
Pharmaceuticals
Calendar
24/05/2024
- Annual General Meeting
| 1st Jan change | Capi. | |
|---|---|---|
| -1.51% | 1.26B | |
| +33.25% | 704B | |
| +28.59% | 577B | |
| -3.55% | 348B | |
| +18.16% | 327B | |
| +4.36% | 288B | |
| +14.81% | 234B | |
| +4.93% | 198B | |
| -9.78% | 194B | |
| -3.69% | 147B |
- Stock Market
- Equities
- 000650 Stock
